Copan Diagnostics is categorized under Biologicals and Allied Products in Murrieta, CA and active since 1994.
Copan Diagnostics was established in 1994, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Biologicals and Allied Products business, which does work in the BOTH market, and is classified as a Biologicals and Allied Products, under code number 3391120 by the NAICS.
If you are seeking more information, feel free to contact Norman Sharples, Owner at the company’s single location by writing to 26055 Jefferson Avenue, Murrieta, California CA 92562 or by phoning (951) 696-4538. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Copan Diagnostics |
Contact Person: | Norman Sharples, Owner |
Address: | 26055 Jefferson Avenue, Murrieta, California 92562 |
Phone Number: | (951) 696-4538 |
Website Address: | copanusa.com |
Annual Revenue (USD): | $5.000.000 to $9.999.999 |
Founded: | 1994 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B & B2C |
Business Category: | Biologicals and Allied Products |
SIC Code: | 5122 |
NAICS Code: | 3391120 |
Share This Business: |
Copan Diagnostics was started in 1994 to provide professional Biologicals and Allied Products under the SIC code 5122 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Norman Sharples, Owner for inquiries that concern Copan Diagnostics by calling the company number (951) 696-4538, as your correspondence is most welcome. Additionally, the physical location of the single location of Copan Diagnostics can be found at the coordinates 33.53846,-117.18392 as well as the street address 26055 Jefferson Avenue in Murrieta, California 92562.
For its online presence, you may visit Copan Diagnostics’s website at copanusa.com and engage with its social media outlets through on Twitter and on Facebook.